Dr. Margaret Kemeny, MD
Claim this profileQueens Cancer Center of Queens Hospital
Studies Breast Cancer
Studies Tumors
5 reported clinical trials
7 drugs studied
Area of expertise
1Breast Cancer
Stage I
Stage II
Stage III
2Tumors
Stage IV
MMR positive
MMR negative
Affiliated Hospitals
Queens Cancer Center Of Queens Hospital
Queens Hospital Center
Clinical Trials Margaret Kemeny, MD is currently running
Dostarlimab
for Advanced Cancer
This trial is testing dostarlimab, a medicine that helps the immune system fight cancer, in patients with advanced solid tumors who have limited treatment options. It works by blocking a protein that allows cancer cells to hide from the immune system. Dostarlimab has garnered extensive interest for its ability to activate the immune system to respond to cancer cells.
Recruiting1 award Phase 110 criteria
TEAMWork App
for Breast Cancer
The purpose of this study is learn more about how being treated for breast cancer affects patients' employment. Researchers are testing an early version of a mobile app designed to help breast cancer patients keep their jobs during and after treatment. The app provides advice for patients to use when having conversations about breast cancer with their employers and their doctors. The app is called TEAMWork (Talking to Employers And Medical staff about Work). In this study, the investigators are asking breast cancer patients who are about to receive treatment or who are currently receiving treatment to tell us what aspects of the app work well, so that they can learn how to improve it.
Recruiting1 award N/A28 criteria
More about Margaret Kemeny, MD
Clinical Trial Related2 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Margaret Kemeny, MD has experience with
- Dostarlimab
- Abemaciclib
- Molecular Profiling Of Tumors
- Clinical Germline Analysis
- Developing New Educational Materials About Genetic Testing For A Diverse Group Of Cancer Patients
- TEAMWork App
Breakdown of trials Margaret Kemeny, MD has run
Breast Cancer
Blood Cancers
Solid Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Margaret Kemeny, MD specialize in?
Margaret Kemeny, MD focuses on Breast Cancer and Tumors. In particular, much of their work with Breast Cancer has involved Stage I patients, or patients who are Stage II.
Is Margaret Kemeny, MD currently recruiting for clinical trials?
Yes, Margaret Kemeny, MD is currently recruiting for 2 clinical trials in Jamaica New York. If you're interested in participating, you should apply.
Are there any treatments that Margaret Kemeny, MD has studied deeply?
Yes, Margaret Kemeny, MD has studied treatments such as Dostarlimab, Abemaciclib, Molecular Profiling of Tumors.
What is the best way to schedule an appointment with Margaret Kemeny, MD?
Apply for one of the trials that Margaret Kemeny, MD is conducting.
What is the office address of Margaret Kemeny, MD?
The office of Margaret Kemeny, MD is located at: Queens Cancer Center of Queens Hospital, Jamaica, New York 11432 United States. This is the address for their practice at the Queens Cancer Center of Queens Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.